PD-L2与原发纵隔大B细胞淋巴瘤中区别于PD-L1的谱系相关转录程序相关
本研究利用CRISPR-Cas9同源工程模型、免疫共培养、免疫交互性卵内绒毛尿囊膜(CAM)异种移植及患者数据集整合转录组分析,探讨PD-L1与PD-L2在原发纵隔大B细胞淋巴瘤(PMBCL)中的不同作用。结果显示PD-L1主要与抑制Th1相关免疫信号及影响PD-1阻断反应相关,PD-L2则与维持谱系相关转录程序及不同治疗反应模式相关。
要点
- PD-L1主要与Th1免疫信号抑制及PD-1阻断反应相关
- PD-L2与维持B细胞谱系相关转录程序及不同治疗反应模式相关
- 同时破坏两种配体可增强Th1免疫激活并改变B细胞转录状态
核心结论
- PD-L1与PD-L2在PMBCL中关联不同的免疫与谱系相关状态,为生物学分层策略提供框架。
研究设计与样本
- 研究采用CRISPR-Cas9工程化的同源模型、免疫共培养实验、免疫交互性卵内绒毛尿囊膜(CAM)异种移植系统,以及患者数据集的整合转录组分析。
主要发现
- PD-L1与Th1相关免疫信号的抑制最强相关,并影响对PD-1阻断的反应性。
- PD-L2与谱系相关转录程序的维持及不同的治疗反应模式相关。
- 同时破坏两种配体增强Th1免疫激活,同时改变B细胞转录状态。
- PMBCL队列转录组分析显示PDCD1LG2表达与B细胞身份及信号模块相关,而CD274表达与干扰素应答免疫程序一致。
临床怎么用
- 结果提示PD-L1与PD-L2可能作为区分免疫状态与谱系状态的生物标志物,为探索生物学指导的分层策略提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary mediastinal large B-cell lymphoma (PMBCL) is characterized by recurrent 9p24.1 alterations driving constitutive overexpression of PD-1 ligands and high sensitivity to PD-1 blockade. While PD-L1 is widely used as a biomarker, the tumor-intrinsic functions of PD-1 ligands, and particularly PD-L2, remain poorly defined. Here, we investigated the distinct roles of PD-L1 and PD-L2 in PMBCL using CRISPR-Cas9-engineered isogenic models, immune co-culture assays, an immune-interactive in ovo chorioallantoic membrane (CAM) xenograft system, and integrative transcriptomic analyses of patient datasets. PD-L1 was most strongly associated with restraint of Th1-associated immune signaling and influenced responsiveness to PD-1 blockade, whereas PD-L2 was associated with preservation of lineage-associated transcriptional programs and distinct treatment-response patterns. Combined disruption of both ligands enhanced Th1 immune activation while altering B-cell transcriptional states. Consistent with these findings, transcriptomic analyses in PMBCL cohorts linked PDCD1LG2 expression to B-cell identity and signaling modules, whereas CD274 expression aligned with interferon-responsive immune programs. Together, these results support a model in which PD-L1 and PD-L2 associate with distinct immune and lineage-associated states in PMBCL and provide a framework for exploring biologically informed stratification strategies in this disease.
引用
- Caillot M, Da Rocha A, Lafenêtre M, et al. PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma. Leukemia. 2026. PMID: 42386908. doi:10.1038/s41375-026-03016-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。